| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.086 | 0.005 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.006 |
| mRNA | AZD0530 | FIMM | pan-cancer | AAC | 0.44 | 0.006 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.1 | 0.006 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | 0.1 | 0.006 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.006 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | 0.44 | 0.006 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | 0.086 | 0.007 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | 0.094 | 0.007 |